Business Wire

FDA Additionally Clears RAPID™ Imaging Platform for Use in Selecting Acute Stroke Patients for Clot Removal

MENLO PARK, Calif.--(BUSINESS WIRE)--iSchemaView, the worldwide leader in advanced imaging for stroke, today announced that the FDA has cleared the RAPID neuroimaging platform for use in selecting ...
The American Journal of Managed Care

Computed Tomography Perfusion [CTP] In Stroke Management

Kevin Sheth, MD, discusses the role of computed tomography perfusion amid stroke diagnosis. This is a video synopsis/summary of a Post Conference Perspectives involving Kevin Sheth, MD. This is a ...

Rapid Medical(TM)'s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER(TM) 13 in Medium Vessel Stroke

TIGERTRIEVER (TM) 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic ...
Endovascular Today

DISTALS Results Presented for Rapid Medical Tigertriever 13 in MVO Stroke

Rapid Medical announced late-breaking results from the DISTALS trial evaluating the company’s Tigertriever 13 device for ...
Medscape

Neuroimaging of Ischemic Stroke With CT and MRI: Advancing Towards Physiology-Based Diagnosis and Therapy

Expert Rev Cardiovasc Ther. 2009;7(1):29-48. Several additional trials are using identification of a penumbra by neuroimaging for the inclusion of patients. The ReoPro Retavase Reperfusion of Stroke ...
Agence France-Presse

Rapid Medical™’s DISTALS Trial Overwhelmingly Positive, Demonstrating Superior Reperfusion with TIGERTRIEVER™ 13 in Medium Vessel Stroke

Rapid Medical™, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVER™ 13 ...